Results 201 to 210 of about 195,691 (306)

Gross haematuria in the era of anticoagulant therapy - Implications on treatment and diagnostic approaches in a large emergency department patient population. [PDF]

BJUI Compass
Yang Y, Seidl J, Engelmann SU, Haas M, Mayr R, Burger M, Breyer J, Resch M.   +7 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial). [PDF]

Palliat Med
van Hylckama Vlieg MAM, de Beukelaar KJI, Spreeuw RHL, Kruip MJHA, Kuy PHMV, Heide AV, van der Rijt CCD, Geijteman ECT.   +7 more
europepmc   +1 more source

Retroperitoneal haemorrhage and neuropathy complicating anticoagulant therapy

, 1974
P V Curry, P. A. Bacon
openalex   +2 more sources

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Correction: Anticoagulant therapy and altered tissue factor expression protect against experimental placental and cerebral malaria. [PDF]

PLoS Pathog
Andrew AK, Bracken TC, Nazario-Maldonado N, Russ BN, Gonzalvo KT, Brainard BM, Mackman N, Moore JM.   +7 more
europepmc   +1 more source

Effect of anticoagulant and antiplatelet therapy on the occurrence of primary intracerebral hemorrhage

, 2018
Aleksandra Lučić-Prokin, Armin Pakoci, Sanela Popovic, Arsen Uvelin   +3 more
openalex   +2 more sources

Correction to Dosage in: Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. [PDF]

, 2013

openalex   +1 more source

Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis [PDF]

, 2017
Blinder, M., Derfler, M. C, Duncan, J. R, et al,, Lewis, L., Nieters, P., Washington University School of Medicine in St. Louis, Saad, N., Vedantham, S.   +7 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source